Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

During the Trading Day
1.44 -0.07 / -4.64%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.37 -0.07 / -4.86%
 
Volume: 25.0K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$156.8M

Company Description

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health for US, European and other world markets. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.

Contact Information

VIVUS, Inc.
351 East Evelyn Avenue
Mountain View California 94041
P:(650) 934-5200
Investor Relations:

Employees

Shareholders

Other institutional51.40%
Individual stakeholders25.67%
Mutual fund holders15.29%

Top Executives

Seth H. Z. FischerChief Executive Officer & Director
Guy P. MarshVice President-US Operations & General Manager
Svai S. SanfordChief Financial & Accounting Officer
Wesley W. DayVice President-Clinical Development
Santosh T. VargheseVice President-Medical & Regulatory Affairs